Wilterding Mark sold RXST
September 5, 2026 · Form 4 insider transaction
Wilterding Mark sold 258,770 shares of RxSight, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share.; Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.